Phase 2 Gynecologic Clinical Trials
21 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 21 trials
Recruiting
Phase 2
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Gynecologic CancersFallopian Tube CancerPlatinum-sensitive Ovarian Cancer+1 more
AbbVie377 enrolled14 locationsNCT07024784
Recruiting
Phase 2
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
Breast CancerGynecologic CancersOvarian Cancer+7 more
Peking University People's Hospital220 enrolled1 locationNCT07586826
Recruiting
Phase 2
A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors
Advanced Gynecological Malignancies
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.280 enrolled2 locationsNCT07448922
Recruiting
Phase 2
Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies
Cervical CancerEndometrial CancerVaginal Cancer+4 more
University of Utah70 enrolled1 locationNCT05979610
Recruiting
Phase 2
A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer
Mesonephric Gynecologic Cancer
Memorial Sloan Kettering Cancer Center40 enrolled7 locationsNCT05787561
Recruiting
Phase 1Phase 2
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
Endometrial CancerCarcinomaGynecologic Cancer+1 more
University of Alabama at Birmingham37 enrolled1 locationNCT05559879
Recruiting
Phase 2
Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
Gynecologic Disease
Tanta University150 enrolled1 locationNCT07043322
Recruiting
Phase 2
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Breast CancerLiver CancerColorectal, Cancer+7 more
University of California, Irvine24 enrolled1 locationNCT07447050
Recruiting
Phase 2
The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)
Gynecologic CancerNeuroendocrine Tumors
University of Utah86 enrolled1 locationNCT07151391
Recruiting
Phase 2
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
Ovarian CancerCervical CancerEndometrial Cancer+5 more
Dana-Farber Cancer Institute32 enrolled2 locationsNCT06677190
Recruiting
Phase 2
Clinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairment in Breast and Gynecological Cancer Patients
Breast CancerGynecologic CancerCancer-related Cognitive Difficulties
University of Utah50 enrolled1 locationNCT07173101
Recruiting
Phase 1Phase 2
A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors
Tumours, Gynecological
GlaxoSmithKline392 enrolled56 locationsNCT06796907
Recruiting
Phase 1Phase 2
A Study of BL-M07D1 in Patients With HER2-expressing Recurrent or Metastatic Gynecologic Malignancies
Gynecological Malignancies
Sichuan Baili Pharmaceutical Co., Ltd.138 enrolled1 locationNCT06131450
Recruiting
Phase 1Phase 2
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies
Solid TumorGynecological Malignant Tumor
Sichuan Baili Pharmaceutical Co., Ltd.38 enrolled1 locationNCT05803018
Recruiting
Phase 2
Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
Gynecologic CancersEsophageal CancerGastrointestinal Cancers
John Waters50 enrolled1 locationNCT07039526
Recruiting
Phase 2
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
Breast CancerSarcomaLung Cancer+6 more
British Columbia Cancer Agency200 enrolled2 locationsNCT04273061
Recruiting
Phase 2
A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced
Gynecological Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.170 enrolled31 locationsNCT06798207
Recruiting
Phase 2
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Breast CancerLiver CancerColorectal, Cancer+7 more
University of California, Irvine51 enrolled1 locationNCT06580002
Recruiting
Phase 2
A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy
Advanced Gynecological Malignancy
Shanghai Hengrui Pharmaceutical Co., Ltd.100 enrolled1 locationNCT06654440
Recruiting
Phase 2
Electrochemotherapy of Gynecological Cancers
Gynecological Cancers
Institute of Oncology Ljubljana30 enrolled1 locationNCT04760327